For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230904:nRSD3371La&default-theme=true
RNS Number : 3371L Rothschild & Co Continuation Fin 04 September 2023
Rothschild & Co Continuation Finance PLC
Half-yearly Report for the six-month period ended 30 June 2023
Interim Management Report
Summary of Important Events
Rothschild & Co Continuation Finance PLC (the "Company") is a wholly-owned
subsidiary of N. M. Rothschild & Sons Limited ("NMR") and was incorporated
on 30 August 2000 to operate as a finance vehicle for the benefit of NMR and
its subsidiaries.
The principal activity of the Company is the raising of finance for the
purpose of lending it to NMR and other companies in NMR's group (the "Group").
The Company raises finance by the issue of perpetual subordinated notes
guaranteed by NMR.
Risks and Uncertainties
The principal risks of the Company are credit risk, liquidity risk and market
risk. The Company follows the risk management policies of the parent
undertaking, NMR.
The Company's principal risk is credit exposure to NMR, as the notes issued by
the Company have been guaranteed by, and funds have been on-lent to NMR. The
Company is therefore reliant on the ability of NMR to meet its obligations
under these lending arrangements. NMR is exposed to current market and
geopolitical headwinds but, nevertheless, has sufficient liquidity to continue
to operate for the next 12 months even in the scenario where revenue is
significantly reduced. Management has considered the going concern basis of
preparation as outlined in note 1 to the financial statements.
This half-yearly financial report has not been audited or reviewed by the
Company's auditors pursuant to the Auditing Practices Board guidance on Review
of Interim Financial Information.
Responsibilities Statement
The Directors confirm that to the best of their knowledge:
- The condensed set of financial statements has been prepared in accordance with
IAS 34 Interim Financial Reporting; and
- The interim management report includes a fair review of (i) the important
events that have occurred during the first six months of the financial year,
and their impact on the condensed set of financial statements, and (ii) the
principal risks and uncertainties for the remaining six months of the
financial year.
By Order of the Board
Peter Barbour
Director
04/09/2023
Condensed Interim Statement of Comprehensive Income
For the six months ended 30 June 2023
6 months to 6 months to
30 June 30 June
2023
2022
Note £ £
Interest income 2,053,754 693,444
Interest expense (2,042,487) (687,002)
Operating profit 11,267 6,442
Revaluation of loans 4 (3,476,570) (24,717,418)
Revaluation of debt securities 9 3,470,275 24,722,319
Foreign exchange translation (losses)/gains (7,337) 1,277
(Loss)/profit before tax (2,365) 12,620
Taxation 3 (4,084) (3,329)
(Loss)/profit for the financial period (6,449) 9,291
Other comprehensive income - -
Total comprehensive (loss)/income for the financial period (6,449) 9,291
Condensed Interim Statement of Changes in Equity
For the six months ended 30 June 2023
Retained Earnings Total shareholders' equity
Share Capital
£ £ £
At 1 January 2023 100,000 324,190 424,190
Total comprehensive loss for the period - (6,449) (6,449)
At 30 June 2023 100,000 317,741 417,741
At 1 January 2022 100,000 304,687 404,687
Total comprehensive income for the period - 9,291 9,291
At 30 June 2022 100,000 313,978 413,978
Condensed Interim Balance Sheet
At 30 June 2023
At 30 June At 31 December
2023 2023 2022 2022
Note £ £ £ £
Non-current assets
Loan to parent undertaking 4 89,372,338 92,848,908
Current assets
Other financial assets 5 625,905 622,569
Cash and cash equivalents 6 269,013 265,057
894,918 887,626
Current liabilities
Current tax liability (3,970) (4,490)
Deferred tax liability 7 (42,519) (37,915)
Other financial liabilities 8 (623,934) (620,572)
Net current assets 224,495 224,649
Total assets less current liabilities 89,596,833 93,073,557
Non-current liabilities
Debt securities in issue 9 (89,179,092) (92,649,367)
Net assets 417,741 424,190
Shareholders' equity
Share capital 11 100,000 100,000
Retained earnings 317,741 324,190
Total shareholders' equity 417,741 424,190
Condensed Interim Cash Flow Statement
For the six months ended 30 June 2023
6 months to 6 months to
30 June 30 June
2023
2022
Note £ £
Cash flow from operating activities
Net (loss)/profit for the financial period (6,449) 9,291
Taxation 4,084 3,329
Net cash (outflow)/inflow from operating activities (2,365) 12,620
Cash flow from financing activities
Net decrease in loans and interest receivable 3,473,234 24,431,389
Net decrease in debt securities in issue and interest payable
(3,466,913) (24,436,447)
Net cash inflow/(outflow) from financing activities 6,321 (5,058)
Net increase in cash and cash equivalents 3,956 7,562
Cash and cash equivalents at beginning of half-year 265,057 250,897
Cash and cash equivalents at end of half-year 6 269,013 258,459
Interest receipts and payments during the period were as follows:
6 months to 6 months to
30 June 2023 30 June 2022
£ £
Interest received from parent undertaking 2,050,418 407,416
Interest paid to note holders 2,039,125 401,130
The Notes to the Condensed Interim Financial Statements form an integral part
of the Condensed Interim Financial Statements.
Notes to the Condensed Interim Financial Statements
(forming part of the Condensed Interim Financial Statements)
For the six months ended 30 June 2023
1. Basis of Preparation
The Condensed Interim Financial Statements are prepared and approved by the
Directors in accordance with IAS 34 Interim Financial Reporting. The Condensed
Interim Financial Statements are prepared under the historical cost accounting
rules and should be read in conjunction with the annual financial statements
for the year ended 31 December 2022, which have been prepared in accordance
with International Financial Reporting Standards.
The accounting policies and methods of valuation are identical to those
applied in the financial statements for the year ended 31 December 2022.
Going Concern
Management has performed an assessment to determine whether there are any
material uncertainties that could cast significant doubt on the ability of the
Company to continue as a going concern. No significant issues have been noted.
In reaching this conclusion, management considered:
- The financial impact of the uncertainty on the Company's balance sheet;
- The Company's liquidity position based on current and projected cash
resources. The liquidity position has been assessed taking into account the
forecast liquidity of NMR and its ability to continue to pay the interest on
the intercompany loan provided by the Company.
Based on the above assessment of the Company's financial position, the
Directors have concluded that the Company has adequate resources to continue
in operational existence for the foreseeable future (for a period of at least
twelve months after the date that the financial statements are signed).
Accordingly, they continue to adopt the going concern basis of accounting in
preparing the annual financial statements.
Financial Risk Management
The Company follows the financial risk management policies of the parent
undertaking, NMR. The key risks arising from the Company's activities
involving financial instruments, which are monitored at the Group level, are
as follows:
- Credit risk - the risk of loss arising from client or counterparty default is
not considered a significant risk to the Company as all asset balances are
with other group companies as detailed in Note 12 Related Party
Transactions.
- Market risk - exposure to changes in market variables such as interest rates,
currency exchange rates, equity and debt prices is not considered significant
as the terms of financial assets substantially match those of financial
liabilities
- Liquidity risk - the risk that the Company is unable to meet its obligations
as they fall due or that it is unable to fund its commitments is not
considered significant as the risk has been transferred to NMR. As the funds
on-lent to NMR have the same maturity dates as the notes issued, the Company's
ability to meet its obligations in respect of notes issued by it is affected
by NMR's ability to make payments to the Company.
2. Directors' Emoluments
None of the directors received any remuneration in respect of their services
to the Company during the period (2022: £nil).
3. Taxation
6 months to 6 months to
30 June 2023
30 June 2022
£ £
Current tax 520 (2,398)
Deferred tax (4,604) (931)
Total tax (4,084) (3,329)
The tax charge can be explained as follows:
6 months to 6 months to
30 June 2023 30 June 2022
£ £
(Loss)/profit before tax (2,365) 12,620
United Kingdom corporation tax credit/(charge) at effective rate 22% (2022: 520 (2,398)
19%)
Deferred tax income statement charge (4,604) (931)
Tax charged for the period (4,084) (3,329)
4. Non-Current Assets: Loan to Parent Undertaking
At 30 June At 31 December
2023 2022
£ £
At beginning of period 92,848,908 114,548,269
Fair value movements (3,476,570) (21,699,361)
At end of period 89,372,338 92,848,908
Due
In 5 years or more 89,372,338 92,848,908
IFRS 9 requires the €150,000,000 loan to be carried at fair value which as
at 30 June 2023 was £89,372,338 (at 31 December 2022: £92,848,908). On an
amortised cost basis, the value of the loan at 30 June 2023 would be
£128,830,562 (at 31 December 2022: £133,027,075). The fair values are based
on the market value of the external debt securities (level 2).
The interest rate charged on the €150 million loan is EUR-TEC10-CNO plus 36
basis points, capped at 9.01% fixed on 05 February, 05 May, 05 August and 05
November each year. The interest rate on the above loan at 30 June 2023 was
3.18% (31 December 2022: 3.12%).
5. Current Assets: Other Financial Assets
At 30 June At 31 December
2023 2022
£ £
Interest receivable 625,905 622,569
6. Cash and Cash Equivalents
At 30 June 2023 the Company held cash of £269,013 (31 December 2022:
£265,057) at the parent undertaking.
7. Deferred Income Taxes
At 30 June At 31 December
2023 2022
£ £
At beginning of period (37,915) (35,869)
Recognised in income:
Income statement charge (4,604) (2,046)
At end of period (42,519) (37,915)
Deferred tax assets less liabilities are attributable to the following items:
At 30 June 2023 At 31 December 2022
£ £
Fair value of intra group loans 8,680,807 7,633,851
Fair value of debt securities in issue (8,723,326) (7,671,766)
(42,519) (37,915)
Both the intra-group loans and debt securities in issue are taxed on an
amortised cost basis of accounting and accordingly taxable/deductible
temporary differences arise following the adoption of IFRS 9.
8. Current Liabilities: Other Financial Liabilities
At 30 June At 31 December
2023 2022
£ £
Interest payable 623,934 620,572
9. Non-Current Liabilities: Debt Securities in Issue
At 30 June At 31 December
2023 2022
£ £
At beginning of period 92,649,367 114,359,489
Fair value movements (3,470,275) (21,710,122)
At end of period 89,179,092 92,649,367
Due
In 5 years or more 89,179,092 92,649,367
Given the IFRS 9 requirement to fair value the related loans, the Company has
elected to fair value the debt securities in issue, which as at 30 June 2023
was £89,179,092 (at 31 December 2022: £92,649,367). On an amortised cost
basis, the value of the debt securities in issue at 30 June 2023 would be
£128,830,562 (at 31 December 2022: £133,027,075). Consistent with the prior
period, the fair value was derived from quoted market prices at the balance
sheet date. In accordance with IFRS 13 and due to a reduction in the frequency
and volume of transactions observed in the immediate run up to the period end,
the fair value is considered to be level 2 as at 30 June 2023 (2022: level 1).
The interest rate payable on the €150 million Perpetual Subordinated Notes
is EUR-TEC10-CNO plus 35 basis points, capped at 9 per cent, fixed on 05
February, 05 May, 05 August and 05 November each year. From and including the
interest payment date falling in August 2016 and every interest payment date
thereafter, the Company may redeem all (i.e. not in part) of the Perpetual
Subordinated Notes at their principal amount.
The interest rate on the above notes at 30 June 2023 was 3.17% (31 December
2022: 3.11%).
10. Maturity of Financial Liabilities
The following table shows contractual cash flows payable by the Company on the
perpetual subordinated notes classified by remaining contractual maturity at
the balance sheet date. Interest cash flows on perpetual subordinated notes
are shown up to five years only, with the principal balance being shown in the
perpetual column.
At 30 June 2023
3 months
or less 1 year 5 years
but not or less or less
payable on but over but over
Demand demand 3 months 1 year Perpetual Total
£ £ £ £ £ £
Perpetual subordinated notes
- 1,020,982 3,062,947 16,335,715 128,830,562 149,250,206
At 31 December 2022
3 months
or less 1 year 5 years
but not or less or less
payable on but over but over
Demand demand 3 months 1 year Perpetual Total
£ £ £ £ £ £
Perpetual subordinated notes
- 1,034,286 3,102,857 16,548,568 133,027,075 153,712,786
11. Share Capital
At 30 June At 31 December
2023 2022
£ £
Authorised, allotted, called up and fully paid
100,000 Ordinary shares of £1 each 100,000 100,000
12. Related Party Transactions
Parties are considered to be related if one party controls, is controlled by
or has the ability to exercise significant influence over the other party.
This includes key management personnel, the parent company, subsidiaries and
fellow subsidiaries.
Amounts receivable from related parties at the period end were as follows:
At 30 June At 31 December
2023 2022
£ £
Cash and cash equivalents at parent undertaking 269,013 265,057
Accrued interest receivable from parent undertaking 625,905 622,569
Loans to parent undertaking 89,372,338 92,848,908
Amounts recognised in the condensed statement of comprehensive income in
respect of related party transactions were as follows:
6 months to 6 months to
30 June 2023 30 June 2022
£ £
Interest income from parent undertaking 2,053,754 693,444
There were no loans made to Directors during the period (6 months to 30 June
2022: none) and no balances outstanding at the period end (at 31 December
2022: £nil). There were no employees of the Company during the period (6
months to 30 June 2022: none).
13. Parent Undertaking and Ultimate Holding Company and Registered
Office
The largest group in which the results of the Company are consolidated is that
headed by Rothschild & Co Concordia SAS, incorporated in France, and whose
registered office is at 23bis, Avenue de Messine, 75008 Paris. The smallest
group in which they are consolidated is that headed by Rothschild & Co
SCA, a French public limited partnership whose registered office is also at
23bis, Avenue de Messine, 75008 Paris. The accounts are available on the
Rothschild & Co website at www.rothschildandco.com.
The Company's immediate parent company is N. M. Rothschild and Sons Limited,
incorporated in England and Wales and whose registered office is at New Court,
St Swithins Lane, London, EC7N 8AL.
The Company's registered office is located at New Court, St Swithin's Lane,
London, EC4N 8AL.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END IR NKQBBOBKDBCK